Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Nasal Influenza Immunisation in Egg Allergic Children (SNIFFLE)
2013-002031-26Phase 4Terminated
- Sponsor
- University Hospital Southampton
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by University Hospital Southampton. Primary endpoint: Immediate allergic reaction to Fluenz intranasal vaccination. Started May 2013; status: terminated.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-002031-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002031-26.